pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 14·1 min read
save

MIT reports 10% drop in research output and 20% fall in graduate admissions amid funding and immigration challenges

May 14, 2026·read at STAT ↗Negative

MIT President Sally Kornbluth announced that the institute's research enterprise is 10% smaller than a year ago.

The university also said graduate admissions for the 2026-2027 year are down 20%, citing reduced federal research funding, higher taxes on endowments, and tighter immigration rules that deter international applicants.

Kornbluth warned that the contraction could limit the pipeline of basic research and future scientists, which she described as a loss for the nation.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: MIT says research has fallen 10%, and grad student enrollment is down”

read at STAT ↗
425 words · retrieved May 14
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 44m agoHow voters feel about trans rights and abortion access will soon be put to the testSTAT
  • 1h agoSTAT+: Dana-Farber, Beth Israel to begin construction of new $1.68 billion cancer hospitalSTAT
  • 3h agoSTAT+: Launch prices for new medicines dipped slightly last year but remain high, analysis findsSTAT
  • 5h agoOpinion: Resident physicians may lose some of their most important work hour protectionsSTAT
  • 5h agoSTAT+: The key health care ballot measures we’re watching in the midtermsSTAT